In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amersham Little Help to GE Healthcare in This Down Market

Executive Summary

As befits this struggling economy, each of the Big Three in diagnostic imaging sounded downbeat in their 2008 year-end financial assessments. But more so than the other two, GE Healthcare focuses on the development of new imaging agents, owing to its acquisition of Amersham in late 2003. Ant that integration has been admittedly slow.
Advertisement

Related Content

GE Acquires Clarient To Anchor Its Molecular IVD Business
GE Acquires Clarient To Anchor Its Molecular IVD Business
The Pace of Development of Molecular Imaging Agents
The Pace of Development of Molecular Imaging Agents
Diagnostics Imaging Sector Hit By Hospitals’ Dwindling Access To Capital
Diagnostics Imaging Sector Hit By Hospitals’ Dwindling Access To Capital
What's Next for Abbott in IVD?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003248

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel